Cogent Biosciences, Inc.

COGT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 5, 2026 4
8-K Sep 2, 2026 8-K
4 Aug 31, 2026 4
144 Aug 27, 2026
SCHEDULE 13G/A Aug 13, 2026
8-K Aug 10, 2026 8-K
424B5 Aug 10, 2026 424B5
10-Q Aug 10, 2026 10-Q
8-K Aug 10, 2026 8-K
SCHEDULE 13G Jul 31, 2026
SCHEDULE 13G/A Jul 27, 2026
4 Jul 6, 2026 4
4 Jun 11, 2026 4
4 Jun 11, 2026 4
4 Jun 11, 2026 4
4 Jun 11, 2026 4
4 Jun 11, 2026 4
4 Jun 11, 2026 4
8-K Jun 11, 2026 8-K
4 May 21, 2026 4
SCHEDULE 13G/A May 14, 2026
10-Q May 5, 2026 10-Q
8-K May 5, 2026 8-K
ARS Apr 23, 2026 ARS
DEFA14A Apr 23, 2026 DEFA14A
← Newer Page 1 of 25 · 614 filings Older →